A phase II multidose study of intravenous PEG-uricase [pegloticase] in patients with refractory gout.
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2014
At a glance
- Drugs Pegloticase (Primary)
- Indications Gout
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.